Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Katanin regulatory subunit B1 like 1 pseudogene 4 (KATNBL1P4) is classified as a pseudogene in the human genome, meaning that it resembles a protein-coding gene related to the katanin regulatory subunit B1 family but is not itself translated into a functional protein. Pseudogenes such as KATNBL1P4 typically do not produce functional products, though some have been shown to play regulatory roles at the RNA level (for example, by acting as decoys for microRNAs or regulating gene expression through other RNA-mediated mechanisms). However, there is currently no evidence that KATNBL1P4 is involved in disease, physiological functions, or therapeutic targeting. It is annotated primarily as a non-functional genomic locus, and there are no known drug interactions, biomarker status, or associated safety concerns specific to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Katanin regulatory subunit B1 like 1 pseudogene 4 (KATNBL1P4).